Citius Oncology Inc. (CTOR)
NASDAQ: CTOR
· Real-Time Price · USD
1.91
0.03 (1.60%)
At close: Oct 03, 2025, 2:29 PM
1.60% (1D)
| Bid | 1.87 |
| Market Cap | 159.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -26.58M |
| EPS (ttm) | -0.39 |
| PE Ratio (ttm) | -4.9 |
| Forward PE | -14.07 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 1.91 |
| Volume | 121,803 |
| Avg. Volume (20D) | 962,461 |
| Open | 1.89 |
| Previous Close | 1.88 |
| Day's Range | 1.83 - 1.95 |
| 52-Week Range | 0.55 - 6.19 |
| Beta | 3.01 |
| Ex-Dividend Date | n/a |
About CTOR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTOR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+7.36%
Citius Oncology and Citius Pharmaceuticals shares ...
Unlock content with
Pro Subscription
2 months ago
-31.21%
Citius Oncology shares are trading lower after the company announced a $15 million offering.